Poor inhaler technique tied to weaker results in COPD

Clinical takeaway: When a COPD patient's bronchodilator seems to underperform, technique is worth checking before escalating therapy. Cognitive impairment and poor manual dexterity were the factors most tied to misuse, and emphasizing a five-to-10-second breath hold may capture much of the benefit.

Inhaler misuse is common in COPD and often blamed on inadequate training. Less examined is whether specific patient physical and cognitive abilities help to predict who struggles, and whether technique measurably changes how well a bronchodilator works. Whether better technique actually improves lung function had drawn only weak, inconsistent evidence in a prior systematic review. This US cohort study tested cognition, manual dexterity, and inspiratory flow in outpatients, then watched patients dose with their own inhalers and remeasured lung function 30 minutes later.

About seven in ten patients (71%) used their inhalers acceptably, so roughly a third fell short. Among those assessed, technique tracked with the drug effect. At 30 minutes after dosing, forced expiratory volume in one second (FEV1) rose by 105 ml in the acceptable-technique group versus 69 ml in those with unacceptable technique, a difference of 36 ml. Forced vital capacity (FVC) showed the same pattern.

Of the five technique steps, only holding the breath for five to 10 seconds tracked with a measurable gain in lung function, and that benefit appeared in patients with normal cognition but not in those with cognitive impairment. Three patient factors were each tied to misuse on their own: cognitive impairment (present in 10.3%), non-functional manual dexterity (34.8%), and low peak inspiratory flow (20.5%). But in a combined analysis, cognitive impairment was the largest factor, tripling the odds of unacceptable technique.

This was a prospective cohort study at nine US pulmonary clinics that enrolled 503 stable outpatients on maintenance handheld bronchodilators, with a mean age of 70. Trained observers graded each patient's real-world use of their own device against a standardized five-item checklist, then screened cognition, hand dexterity, and peak inspiratory flow. Patients with diagnosed dementia were excluded, which keeps the cognitive-impairment rate on the low side.

Inhaler choice in COPD leans heavily on lung function and formulary, but this study suggests the patient's own capacities, whether they can follow the steps and hold a breath on cue, help determine whether the drug reaches the airways at all. That points toward matching the delivery system to the person, not just the diagnosis.

Optimally, watch a patient use their own inhaler. This check may explain a disappointing response before the regimen gets escalated. When cognition or dexterity is the barrier, a pressurized metered-dose inhaler (pMDI) with a valved holding chamber, or a nebulizer, may work better, though the authors frame both as options for cases where a caregiver can assist.

"Proper inhaler technique remains one of the most important and modifiable factors in COPD treatment. Our findings reinforce that selecting the right inhaled medication delivery system requires more than understanding a person's lung function alone," said lead author Donald A. Mahler, MD, of the Geisel School of Medicine at Dartmouth.

He continued, "Health care providers should consider cognitive function, manual dexterity, and inhalation ability when choosing and reviewing inhaled therapies to ensure people receive the greatest possible benefit from their prescribed treatments."

Source: Mahler DA, et al. (2026 May 27) Ann Am Thorac Soc. Inhaler Technique in Chronic Obstructive Pulmonary Disease: Patient Impairments and Bronchodilation